Literature DB >> 32387649

Differential effects of SNARE-dependent gliotransmission on behavioral phenotypes in a mouse model of Huntington's disease.

Annesha C King1, Tara E Wood2, Efrain Rodriguez2, Vladimir Parpura3, Michelle Gray4.   

Abstract

Huntington's disease (HD) is a dominantly inherited neurodegenerative disease caused by a polyglutamine expansion in the widely expressed huntingtin protein. Multiple studies have indicated the importance of mutant huntingtin (mHTT) in astrocytes to HD pathogenesis. Astrocytes exhibit SNARE-dependent exocytosis and gliotransmission, which can be hampered by transgenic expression of dominant negative SNARE (dnSNARE) in these glial cells. We used BACHD mice and crossed them with the dnSNARE model to determine if pan-astrocytic SNARE-dependent exocytosis plays an important role in vivo in the progression of HD behavioral phenotypes. We assessed motor and neuropsychiatric behaviors in these mice. At 12 months of age there was a significant improvement in motor coordination (rotarod test) in BACHD/dnSNARE mice when compared to BACHD mice. Analyses of open field performance revealed significant worsening of center entry (at 9 and 12 months), but not distance traveled in BACHD/dnSNARE when compared to BACHD mice, and variable/inconclusive results on vertical plane entry. While no differences between BACHD and BACHD/dnSNARE mice at 12 months of age in the forced swim test were found, we did observe a significant decrease in performance of BACHD/dnSNARE mice in the light-dark box paradigm. Thus, reduction of astrocytic SNARE-dependent exocytosis has differential effects on the psychiatric-like and motor phenotypes observed in BACHD mice. These data suggest broadly targeting SNARE-dependent exocytosis in astrocytes throughout the brain as a means to modulate gliotransmission in HD may contribute to worsening of specific behavioral deficits and perhaps a brain-region specific approach would be required.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Astrocytes; BACHD; Full-length mutant huntingtin; Gliotransmission; Huntingtin; Huntington's disease; dnSNARE

Mesh:

Substances:

Year:  2020        PMID: 32387649      PMCID: PMC7313419          DOI: 10.1016/j.expneurol.2020.113358

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  68 in total

1.  Synaptic islands defined by the territory of a single astrocyte.

Authors:  Michael M Halassa; Tommaso Fellin; Hajime Takano; Jing-Hui Dong; Philip G Haydon
Journal:  J Neurosci       Date:  2007-06-13       Impact factor: 6.167

2.  Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease.

Authors:  Geraldine Kong; Kim-Anh Lê Cao; Louise M Judd; ShanShan Li; Thibault Renoir; Anthony J Hannan
Journal:  Neurobiol Dis       Date:  2018-09-05       Impact factor: 5.996

Review 3.  Gliotransmission: Beyond Black-and-White.

Authors:  Iaroslav Savtchouk; Andrea Volterra
Journal:  J Neurosci       Date:  2018-01-03       Impact factor: 6.167

4.  Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice.

Authors:  Jennifer Bradford; Ji-Yeon Shin; Meredith Roberts; Chuan-En Wang; Guoqing Sheng; Shihua Li; Xiao-Jiang Li
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

5.  Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss.

Authors:  Michael M Halassa; Cedrick Florian; Tommaso Fellin; James R Munoz; So-Young Lee; Ted Abel; Philip G Haydon; Marcos G Frank
Journal:  Neuron       Date:  2009-01-29       Impact factor: 17.173

6.  Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.

Authors:  Kevin Duff; Jane S Paulsen; Leigh J Beglinger; Douglas R Langbehn; Julie C Stout
Journal:  Biol Psychiatry       Date:  2007-05-03       Impact factor: 13.382

Review 7.  The Biology of Huntingtin.

Authors:  Frédéric Saudou; Sandrine Humbert
Journal:  Neuron       Date:  2016-03-02       Impact factor: 17.173

8.  Astrocyte control of synaptic NMDA receptors contributes to the progressive development of temporal lobe epilepsy.

Authors:  Jerome Clasadonte; Jinghui Dong; Dustin J Hines; Philip G Haydon
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

Review 9.  Vesicular transmitter release from astrocytes.

Authors:  Vedrana Montana; Erik B Malarkey; Claudia Verderio; Michela Matteoli; Vladimir Parpura
Journal:  Glia       Date:  2006-11-15       Impact factor: 8.073

10.  Astrocytes modulate brainstem respiratory rhythm-generating circuits and determine exercise capacity.

Authors:  Shahriar Sheikhbahaei; Egor A Turovsky; Patrick S Hosford; Anna Hadjihambi; Shefeeq M Theparambil; Beihui Liu; Nephtali Marina; Anja G Teschemacher; Sergey Kasparov; Jeffrey C Smith; Alexander V Gourine
Journal:  Nat Commun       Date:  2018-01-25       Impact factor: 14.919

View more
  2 in total

1.  BACHD Mice Recapitulate the Striatal Parvalbuminergic Interneuron Loss Found in Huntington's Disease.

Authors:  Vyshnavi Rallapalle; Annesha C King; Michelle Gray
Journal:  Front Neuroanat       Date:  2021-05-24       Impact factor: 3.856

2.  Mutant Huntingtin Protein Interaction Map Implicates Dysregulation of Multiple Cellular Pathways in Neurodegeneration of Huntington's Disease.

Authors:  Sonia Podvin; Sara Brin Rosenthal; William Poon; Enlin Wei; Kathleen M Fisch; Vivian Hook
Journal:  J Huntingtons Dis       Date:  2022
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.